Wintac Ltd. | Income Statement

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
304,775.50
290,761.50
180,985.20
328,020.90
443,496.00
719,201
Cost of Goods Sold (COGS) incl. D&A
291,365.40
306,070.80
315,576.90
387,416.90
399,129.00
547,556
Gross Income
13,410.10
15,309.30
134,591.70
59,396.00
44,367.00
171,645
SG&A Expense
28,074.40
29,148.10
26,759.50
44,270.90
139,562.00
127,100
EBIT
30,446.10
56,535.70
168,761.70
107,243.00
95,195.00
44,545
Unusual Expense
34,915.80
27,209.40
16,092.50
15,818.50
-
-
Non Operating Income/Expense
1,127.60
7,297.40
3,745.50
6,457.50
7,188.00
33,108
Interest Expense
3,069.10
672.60
7,394.80
13,492.30
8,991.00
9,338
Pretax Income
64,702.00
76,652.10
163,406.10
97,600.60
96,998.00
2,099
Income Tax
5,241.90
15,104.50
12,085.60
10,718.00
924.00
1,008
Consolidated Net Income
69,943.90
61,547.50
151,320.50
86,882.60
97,922.00
1,091
Net Income
69,943.90
61,547.50
151,320.50
86,882.60
97,922.00
1,091
Net Income After Extraordinaries
69,943.90
61,547.50
151,320.50
86,882.60
97,922.00
1,091
Net Income Available to Common
69,943.90
61,547.50
151,320.50
86,882.60
97,922.00
1,091
EPS (Basic)
6.98
6.14
15.10
8.67
9.77
0.11
Basic Shares Outstanding
10,024.20
10,024.20
10,024.20
10,024.20
-
-
EPS (Diluted)
6.98
6.14
15.10
8.67
-
-
Diluted Shares Outstanding
10,024.20
10,024.20
10,024.20
10,024.20
-
-
EBITDA
11,648.60
20,165.30
130,087.60
70,925.20
59,730.00
86,358
Other Operating Expense
15,781.70
12,078.30
7,410.50
3,576.20
-
-
Non-Operating Interest Income
4,856.60
468.30
403.40
780.50
-
-

About Wintac

View Profile
Address
No. 54/1, Budihal
Bangalore Karnataka 562123
India
Employees -
Website http://www.wintaclimited.com
Updated 07/08/2019
Wintac Ltd. engages in the development, manufacture, and market of pharmaceutical formulations. Its focuses on the manufacture of parenterals, sterile ophthalmic preparations and also marketing of pharmaceutical specialties. The company was founded in 1987 and is headquartered in Bangalore, India.